Interaction Guide · Research summary

Can I take Angelica Sinensis with Phenobarbital?

Review Angelica Sinensis with Phenobarbital: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

An exact dong quai interaction with phenobarbital has not been established. Dong quai can cause light-sensitive skin reactions, so review the product before using it.

What this answer covers

Oral Angelica sinensis products; no assumption that other Angelica species or isolated constituents behave identically.

Supplement or preparation
Angelica sinensis
Medication ingredient
phenobarbital

What the evidence actually concerns

The institutional assessment lists photosensitivity and photodermatitis from dong quai. That is a possible effect of the herb itself, rather than a measured increase caused by this exact drug combination.

Check the botanical and all ingredients

Confirm that the product contains Angelica sinensis and note the dose, extract and any added herbs. Different species, mixtures and isolated compounds cannot be treated as the same exposure.

Discuss a new skin reaction

If you develop unusual sun sensitivity, itching or redness, contact a clinician and bring the product label. The evidence does not establish that separating doses prevents a skin reaction.

Keep the prescribed medicine steady

Do not stop phenobarbital abruptly or adjust its dose to compensate for a supplement. Sudden withdrawal can provoke serious seizures. Tell the prescriber about new or worsening symptoms and all supplement changes.

Evidence and practical considerations

Side effects & toxicity

Intrinsic dong quai photosensitivity does not establish the current exact-pair photosensitivity or avoid/separate claim.

Exact scope
Oral Angelica sinensis products; no assumption that other Angelica species or isolated constituents behave identically. with Exact oral phenobarbital; parent and metabolites distinguished; no other drug/route assumed equivalent.
Medication form and route
oral supplement unless pregnancy section explicitly distinguishes neonatal injection
Timing or duration
Preparation, dose and duration determine applicability; chronic nutrition evidence is not a single-dose interaction.

What remains uncertain

  • No exact human co-use study identified; no validated interval or demonstrated additive photosensitivity.

Factors that may matter: exact supplement identity; dose; other medicines; clinical indication; baseline nutrition; pregnancy where relevant.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral phenobarbital.

Causes CNS depression and can impair driving; other CNS depressants can add to these effects. Adult plasma half-life is prolonged. Abrupt withdrawal after dependence can cause seizures and other serious symptoms. Long-term treatment warrants periodic clinical and laboratory assessment.

How this applies: Exact RxCUI 8134 IN and UNII YQE403BP4D, oral plain ingredient; no automatic sodium-injection or other barbiturate transfer.

Does not name the requested botanicals or establish supplement-specific interaction rates or spacing. Current DailyMed listing is unapproved drug other, not evidence of FDA approval.

Source 2: institutional botanical assessment

mskcc.org · Source check Sep 10, 2026

Population: Users of Angelica sinensis products.

Lists photosensitivity/photodermatitis as possible adverse effects. Does not identify an exact phenobarbital or primidone combination study.

How this applies: Supports a supplement-specific skin precaution while leaving exact combination claims insufficient.

Secondary institutional context. Intrinsic photosensitivity is not proof of additive drug photosensitivity. Experimental CYP findings cannot establish a primidone interaction.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Exact current available claims reviewed against captured originals; no clinical review asserted.
Research summary published

Article revision: bc7e9b29390b85a6

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.